enzalutamide approved for prostate cancer with biochemical recurrence: stephen freedland, md
Published 7 months ago • 5.2K plays • Length 13:24Download video MP4
Download video MP3
Similar videos
-
18:58
talapro-2 study of talazoparib/enzalutamide in prostate cancer: stephen freedland and neeraj agarwal
-
0:53
dr. freedland on real-world utility of enzalutamide in prostate cancer
-
7:20
mcspc: real world characteristics and treatment by disease volume with stephen freedland, md
-
2:17
enzalutamide for biochemically recurrent prostate cancer | nejm
-
2:00
freedland: early adt after recurrence following rp
-
2:00
freedland: early adt after recurrence following rp
-
1:58:44
prostate cancer | beyond the guidelines: urologic oncology investigators provide perspectives on ...
-
1:09
considerations for apalutamide versus enzalutamide in prostate cancer treatment
-
0:18
the #innovate trial is for patients with node-positive #prostatecancer.
-
8:42
enzalutamide and prostvac for recurrent disease
-
2:37
arches trial: enzalutamide plus adt for mhspc
-
1:03
dr. daniel petrylak on the role of enzalutamide in prostate cancer
-
24:49
a journal article review enzalutamide in metastatic prostate cancer before chemotherapy
-
12:08
new fda approval: darolutamide for hormone-sensitive disease | mark scholz, md | pcri
-
1:30
terrain trial of enzalutamide versus bicalutamide for advanced prostate cancer
-
1:03
dr. azad on the benefit of adding enzalutamide to adt in mhspc
-
1:12
dr. pal on sequencing abiraterone and enzalutamide in mcrpc
-
1:52
clinical trial of enzamet shows it promising as prostate cancer treatment
-
1:06
dr. bradley on adverse events associated with enzalutamide and apalutamide in prostate cancer